1st Quarter - Report
K&L GATES, LLP for IMPEL NEUROPHARMA, INC.
Firm
Client
Income
—
Expenses
—
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
Issues relating to federal funding for development of advanced drug delivery devices for defense applications (no specific legislation at this time).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE SWEENEY ANTHONY | — |
| EDWARD CHARLES OLIVARES | — |
Budget/Appropriations BUD
Issues relating to federal funding for development of advanced drug delivery devices for defense applications (no specific legislation at this time).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELISE SWEENEY ANTHONY | — |
| EDWARD CHARLES OLIVARES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.